MarketCap
Facebook
X
Telegram
DexCom EV/EBITDA Ratio | DXCM
Annual EV/EBITDA Ratio DexCom
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24.2 | 36.1 | 66.9 | 81.7 | 146 | 99.7 | 117 | -79.8 | -190 | -132 | -121 | -338 | -126 | -21 | -17.5 | -3.51 | 0.0828 | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 146 | -338 | -26.9 |
EV/EBITDA Ratio of other stocks in the Diagnostics research industry
| Issuer | EV/EBITDA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Waters Corporation
WAT
|
60.2 | $ 476.29 | -0.09 % | $ 28.4 B |  USA |
 |
Exagen
XGN
|
-6.55 | $ 5.26 | -25.92 % | $ 113 M | USA |
 |
Celcuity
CELC
|
-32.4 | $ 67.13 | -4.11 % | $ 3.14 B | USA |
 |
Laboratory Corporation of America Holdings
LH
|
16 | $ 370.89 | -0.25 % | $ 30.9 B | USA |
 |
Lantheus Holdings
LNTH
|
15.5 | $ 101.65 | 0.63 % | $ 6.86 B | USA |
 |
Accelerate Diagnostics
AXDX
|
-2.05 | - | -61.36 % | $ 2.46 M | USA |
 |
Medpace Holdings
MEDP
|
24.9 | $ 664.97 | -1.18 % | $ 19.2 B | USA |
 |
Charles River Laboratories International
CRL
|
26.6 | $ 346.21 | -2.02 % | $ 17.2 B | USA |
 |
Mettler-Toledo International
MTD
|
627 | $ 1 750.2 | -0.69 % | $ 36.1 B |  Schweiz |
 |
Danaher Corporation
DHR
|
26.6 | $ 236.19 | 0.46 % | $ 168 B | USA |
 |
Koninklijke Philips N.V.
PHG
|
17.1 | $ 30.39 | -1.32 % | $ 28.8 B |  Niderland |
 |
RadNet
RDNT
|
33.9 | $ 77.91 | -0.6 % | $ 5.86 B | USA |
 |
Senseonics Holdings
SENS
|
-5.62 | $ 10.05 | 2.55 % | $ 419 M | USA |
 |
Neuronetics
STIM
|
-6.02 | $ 2.01 | -7.8 % | $ 133 M | USA |
 |
T2 Biosystems
TTOO
|
-1.13 | - | -39.35 % | $ 313 K | USA |
 |
Thermo Fisher Scientific
TMO
|
21.2 | $ 719.09 | -0.35 % | $ 271 B | USA |
 |
Biocept
BIOC
|
-0.496 | - | -13.05 % | $ 7.29 M | USA |
 |
Guardant Health
GH
|
-38.2 | $ 155.43 | -2.12 % | $ 19.5 B | USA |
 |
Akumin
AKU
|
23.4 | - | -17.87 % | $ 25.9 M |  Canada |
 |
Brainsway Ltd.
BWAY
|
166 | $ 10.63 | -8.68 % | $ 361 M |  Israel |
 |
VolitionRx Limited
VNRX
|
-3.21 | $ 0.19 | -6.2 % | $ 23.9 M |  Singapore |
 |
Natera
NTRA
|
-112 | $ 311.81 | -1.92 % | $ 42.6 B | USA |
 |
IQVIA Holdings
IQV
|
14.9 | $ 275.46 | -1.21 % | $ 47.4 B | USA |
 |
Agilent Technologies
A
|
20.2 | $ 178.84 | -0.74 % | $ 50.8 B | USA |
 |
Quotient Limited
QTNT
|
-2.83 | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Chembio Diagnostics
CEMI
|
-1.86 | - | 0.22 % | $ 16.8 M | USA |
 |
DermTech
DMTK
|
-0.68 | - | -11.32 % | $ 2.94 M | USA |
 |
Surmodics
SRDX
|
189 | - | - | $ 608 M | USA |
 |
Invitae Corporation
NVTA
|
44.6 | - | - | $ 21.2 M | USA |
 |
Syneos Health
SYNH
|
7.06 | - | - | $ 4.46 B | USA |
 |
Motus GI Holdings
MOTS
|
-0.0496 | - | -34.28 % | $ 263 K | Israel |
 |
Heska Corporation
HSKA
|
-134 | - | - | $ 1.31 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
-0.156 | - | -20.0 % | $ 1.06 M | USA |
 |
Renalytix AI plc
RNLX
|
-1.16 | - | 5.66 % | $ 22.7 M |  Britain |
 |
Psychemedics Corporation
PMD
|
-2.23 | - | -1.84 % | $ 15.3 M | USA |
 |
Meridian Bioscience
VIVO
|
18.4 | - | - | $ 1.49 B | USA |
 |
Quest Diagnostics Incorporated
DGX
|
10.8 | $ 258.38 | -0.5 % | $ 28.7 B | USA |
 |
Castle Biosciences
CSTL
|
-227 | $ 34.41 | 0.07 % | $ 997 M | USA |
 |
IDEXX Laboratories
IDXX
|
35 | $ 696.77 | -1.4 % | $ 56 B | USA |
 |
Illumina
ILMN
|
22.1 | $ 214.84 | -2.69 % | $ 33.3 B | USA |
 |
Anixa Biosciences
ANIX
|
-0.0846 | $ 3.05 | -3.48 % | $ 99 K | USA |
|
Biodesix
BDSX
|
-8.27 | $ 10.04 | -2.95 % | $ 75.8 M | USA |
 |
BioNano Genomics
BNGO
|
-1.43 | $ 1.25 | 7.66 % | $ 6.81 M | USA |
 |
Bioventus
BVS
|
10 | $ 11.18 | 1.5 % | $ 745 M | USA |
 |
Fulgent Genetics
FLGT
|
-8.71 | $ 25.83 | -1.22 % | $ 795 M | USA |
 |
CareDx, Inc
CDNA
|
-65.8 | $ 80.78 | -4.31 % | $ 4.3 B | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
-73.4 | - | - | $ 562 M | Britain |
 |
Biomerica
BMRA
|
-1.7 | $ 1.48 | -4.52 % | $ 4.31 M | USA |
 |
Interpace Biosciences
IDXG
|
3.62 | $ 7.0 | -13.43 % | $ 31 M | USA |